What question did this study set out to answer?

Synthesize current clinical evidence regarding the cellular and physiological mechanisms by which glucocorticoid therapy impairs bone remodeling and precipitates secondary osteoporosis.

May 1, 2011PM&R

Adverse Effects of Corticosteroids on Bone Metabolism: A Review

View Full Paper

Ask AI

Bookmark

Authors

RMRaj S. Mitra

Discussion

Member takes

Overview

Review demonstrates increased secondary osteoporosis and fracture risk from glucocorticoid therapy, highlighting the need for preventive bone-protective intervals.

Key Points

Synthesize current clinical evidence regarding the cellular and physiological mechanisms by which glucocorticoid therapy impairs bone remodeling and precipitates secondary osteoporosis.
Reviewed clinical and biological literature examining secondary osteoporosis caused by glucocorticoid (GC) exposure.
Assessed cellular pathways involving osteoblasts, osteoclasts, and osteocytes alongside clinical risk factors and fracture prevention strategies.
Glucocorticoid exposure is the most common cause of drug-induced osteoporosis, accounting for 20% of all osteoporosis cases.
GCs induce apoptosis in osteoblasts and osteocytes to suppress bone formation while simultaneously extending osteoclast lifespan to amplify net bone resorption.
Primary fracture risk factors include age over 65 years, low calcium intake, positive family history, and treatment lasting longer than 3 months, with fracture risk declining 3 months after cessation.

Cite This Study

Raj S. Mitra (2011) studied this question.

synapsesocial.com/papers/6a702e54f44fa9f079ddbe83 https://doi.org/10.1016/j.pmrj.2011.02.017

View Full Paper

Ask AI

Bookmark

May 1, 2011PM&R

Adverse Effects of Corticosteroids on Bone Metabolism: A Review

View Full Paper

Ask AI

Bookmark

Authors

RMRaj S. Mitra

Discussion

Member takes

Overview

Review demonstrates increased secondary osteoporosis and fracture risk from glucocorticoid therapy, highlighting the need for preventive bone-protective intervals.

Key Points

Synthesize current clinical evidence regarding the cellular and physiological mechanisms by which glucocorticoid therapy impairs bone remodeling and precipitates secondary osteoporosis.
Reviewed clinical and biological literature examining secondary osteoporosis caused by glucocorticoid (GC) exposure.
Assessed cellular pathways involving osteoblasts, osteoclasts, and osteocytes alongside clinical risk factors and fracture prevention strategies.
Glucocorticoid exposure is the most common cause of drug-induced osteoporosis, accounting for 20% of all osteoporosis cases.
GCs induce apoptosis in osteoblasts and osteocytes to suppress bone formation while simultaneously extending osteoclast lifespan to amplify net bone resorption.
Primary fracture risk factors include age over 65 years, low calcium intake, positive family history, and treatment lasting longer than 3 months, with fracture risk declining 3 months after cessation.

Cite This Study

Raj S. Mitra (2011) studied this question.

synapsesocial.com/papers/6a702e54f44fa9f079ddbe83 https://doi.org/10.1016/j.pmrj.2011.02.017

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark